FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2914187894> ?p ?o ?g. }

• W2914187894 endingPage "e13113" @default.
• W2914187894 startingPage "e13113" @default.
• W2914187894 abstract "Abstract Rationale: Pancreatic acinar cell carcinoma (PACC) is a relatively rare malignancy of the exocrine pancreas. BRCA2, a cancer susceptibility gene, has been widely studied in breast and ovarian carcinomas as mutation carriers for this gene are at a high risk for cancer development. Olaparib, an oral poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitor, has been approved for the treatment of ovarian cancer with any BRCA 1/2 mutations. Herein, we report the first case of a germline BRCA2-mutated unresectable advanced PACC patient who responded well to olaparib treatment. Patient concerns: A 59-year-old male with a family history of cancer presented with a persistent epigastric dull pain for 3 months. Diagnosis: The patient was diagnosed with advanced PACC based on computed tomography (CT) scan, laparotomy, and pathology. Interventions: Exploratory laparotomy, intratumoral brachytherapy by radioiodine-125 seeds, modified FOLFIRINOX chemotherapy, and targeted therapy with olaparib were administered. Outcomes: The patient responded well to olaparib until the occurrence of severe adverse drug reactions, he died as a result of multiple organ failure with an overall survival period of 12 months. Lessons: As a PARP inhibitor, olaparib has remarkable curative effect not only on breast and ovarian cancers, but also on other malignancies with BRCA mutations. Patients with advanced cancer could benefit from active targeted therapy with improvement in overall survival and quality of life." @default.
• W2914187894 created "2019-02-21" @default.
• W2914187894 creator A5023135321 @default.
• W2914187894 creator A5050942875 @default.
• W2914187894 creator A5052964199 @default.
• W2914187894 creator A5059605240 @default.
• W2914187894 creator A5071190598 @default.
• W2914187894 date "2018-11-01" @default.
• W2914187894 modified "2023-10-12" @default.
• W2914187894 title "Response of germline BRCA2-mutated advanced pancreatic acinar cell carcinoma to olaparib" @default.
• W2914187894 cites W1595460832 @default.
• W2914187894 cites W1836362594 @default.
• W2914187894 cites W1973268287 @default.
• W2914187894 cites W1980995002 @default.
• W2914187894 cites W1995851961 @default.
• W2914187894 cites W1999247278 @default.
• W2914187894 cites W2016115910 @default.
• W2914187894 cites W2019678947 @default.
• W2914187894 cites W2022293423 @default.
• W2914187894 cites W2023813031 @default.
• W2914187894 cites W2026587982 @default.
• W2914187894 cites W2032219235 @default.
• W2914187894 cites W2034024919 @default.
• W2914187894 cites W2034280129 @default.
• W2914187894 cites W2046964033 @default.
• W2914187894 cites W2051184323 @default.
• W2914187894 cites W2093232036 @default.
• W2914187894 cites W2110920215 @default.
• W2914187894 cites W2118189115 @default.
• W2914187894 cites W2155563954 @default.
• W2914187894 cites W2186348325 @default.
• W2914187894 cites W2280873911 @default.
• W2914187894 cites W2501023632 @default.
• W2914187894 cites W2539944286 @default.
• W2914187894 cites W2562021774 @default.
• W2914187894 cites W2606436364 @default.
• W2914187894 cites W2621271973 @default.
• W2914187894 cites W2773109548 @default.
• W2914187894 cites W4375905885 @default.
• W2914187894 cites W4377205715 @default.
• W2914187894 doi "https://doi.org/10.1097/md.0000000000013113" @default.
• W2914187894 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6250555" @default.
• W2914187894 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30407325" @default.
• W2914187894 hasPublicationYear "2018" @default.
• W2914187894 type Work @default.
• W2914187894 sameAs 2914187894 @default.
• W2914187894 citedByCount "15" @default.
• W2914187894 countsByYear W29141878942018 @default.
• W2914187894 countsByYear W29141878942019 @default.
• W2914187894 countsByYear W29141878942020 @default.
• W2914187894 countsByYear W29141878942021 @default.
• W2914187894 countsByYear W29141878942022 @default.
• W2914187894 countsByYear W29141878942023 @default.
• W2914187894 crossrefType "journal-article" @default.
• W2914187894 hasAuthorship W2914187894A5023135321 @default.
• W2914187894 hasAuthorship W2914187894A5050942875 @default.
• W2914187894 hasAuthorship W2914187894A5052964199 @default.
• W2914187894 hasAuthorship W2914187894A5059605240 @default.
• W2914187894 hasAuthorship W2914187894A5071190598 @default.
• W2914187894 hasBestOaLocation W29141878941 @default.
• W2914187894 hasConcept C104317684 @default.
• W2914187894 hasConcept C121608353 @default.
• W2914187894 hasConcept C126322002 @default.
• W2914187894 hasConcept C143998085 @default.
• W2914187894 hasConcept C182979987 @default.
• W2914187894 hasConcept C185592680 @default.
• W2914187894 hasConcept C2779138821 @default.
• W2914187894 hasConcept C2779962180 @default.
• W2914187894 hasConcept C2780194787 @default.
• W2914187894 hasConcept C2780210213 @default.
• W2914187894 hasConcept C2780427987 @default.
• W2914187894 hasConcept C502942594 @default.
• W2914187894 hasConcept C530470458 @default.
• W2914187894 hasConcept C55493867 @default.
• W2914187894 hasConcept C71924100 @default.
• W2914187894 hasConcept C82381507 @default.
• W2914187894 hasConceptScore W2914187894C104317684 @default.
• W2914187894 hasConceptScore W2914187894C121608353 @default.
• W2914187894 hasConceptScore W2914187894C126322002 @default.
• W2914187894 hasConceptScore W2914187894C143998085 @default.
• W2914187894 hasConceptScore W2914187894C182979987 @default.
• W2914187894 hasConceptScore W2914187894C185592680 @default.
• W2914187894 hasConceptScore W2914187894C2779138821 @default.
• W2914187894 hasConceptScore W2914187894C2779962180 @default.
• W2914187894 hasConceptScore W2914187894C2780194787 @default.
• W2914187894 hasConceptScore W2914187894C2780210213 @default.
• W2914187894 hasConceptScore W2914187894C2780427987 @default.
• W2914187894 hasConceptScore W2914187894C502942594 @default.
• W2914187894 hasConceptScore W2914187894C530470458 @default.
• W2914187894 hasConceptScore W2914187894C55493867 @default.
• W2914187894 hasConceptScore W2914187894C71924100 @default.
• W2914187894 hasConceptScore W2914187894C82381507 @default.
• W2914187894 hasIssue "45" @default.
• W2914187894 hasLocation W29141878941 @default.
• W2914187894 hasLocation W29141878942 @default.
• W2914187894 hasLocation W29141878943 @default.
• W2914187894 hasLocation W29141878944 @default.
• W2914187894 hasLocation W29141878945 @default.

• next